CPHI

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.0146
Percentage change 9.16	%

Peers: SNY ALNY RDY ACHC PCRX MDGL AGEN RCUS LIVN LGND

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.34	Insider Own	51.28%	Shs Outstand	17.86M	Perf Week	-1.69%
Market Cap	3.66M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	9.38M	Perf Month	-9.33%
Income	-4.74M	PEG	-	EPS next Q	-	Inst Own	0.21%	Short Float	1.10%	Perf Quarter	-18.42%
Sales	5.54M	P/S	0.66	EPS this Y	-	Inst Trans	-33.50%	Short Ratio	0.25	Perf Half Y	-34.22%
Book/sh	0.37	P/B	0.48	EPS next Y	-	ROA	-32.92%	Short Interest	0.10M	Perf Year	-65.27%
Cash/sh	0.04	P/C	4.88	EPS next 5Y	-	ROE	-75.07%	52W Range	0.13 - 0.69	Perf YTD	-71.24%
Dividend Est.	-	P/FCF	-	EPS past 5Y	40.63%	ROI	-59.63%	52W High	-74.71%	Beta	0.69
Dividend TTM	-	Quick Ratio	0.26	Sales past 5Y	-10.53%	Gross Margin	-41.00%	52W Low	33.85%	ATR (14)	0.02
Dividend Ex-Date	-	Current Ratio	0.79	EPS Y/Y TTM	81.80%	Oper. Margin	-82.55%	RSI (14)	42.53	Volatility	26.20% 12.85%
Employees	239	Debt/Eq	0.61	Sales Y/Y TTM	-28.76%	Profit Margin	-85.56%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.22	EPS Q/Q	78.04%	Payout	-	Rel Volume	2.22	Prev Close	0.16
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-39.00%	Earnings	-	Avg Volume	415.59K	Price	0.17
SMA20	-8.73%	SMA50	-18.46%	SMA200	-32.64%	Trades		Volume	923,233	Change	9.16%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-10	Initiated	Rodman & Renshaw	Mkt Outperform	$6

Dec-18-24 08:30AM	China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville (PR Newswire) -9.78%
Dec-13-24 08:00AM	China Pharma Announces the Entry of "At-The-Market" Equity Offering (PR Newswire)
Aug-19-24 08:00AM	China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 (PR Newswire)
Feb-23-24 04:05PM	China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split (PR Newswire) -8.07%
Nov-29-23 08:00AM	China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device (PR Newswire) +30.16%
07:34PM	Loading…
Aug-23-23 07:34PM	Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap? (GuruFocus.com) -16.89% -6.33%
Aug-09-23 08:30AM	China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs (PR Newswire)
Feb-24-23 04:05PM	China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split (PR Newswire) -17.24%
Dec-28-22 08:00AM	China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask (PR Newswire)
Dec-15-22 08:00AM	China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 (PR Newswire) -10.01%
Dec-05-22 08:00AM	China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project (PR Newswire) +44.38%
Dec-02-22 04:10PM	China Pharma Announces Receipt of Noncompliance Notice from NYSE American (PR Newswire)
Oct-01-22 10:05PM	China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency (PR Newswire)
Jul-18-22 08:00AM	China Pharma Announced the Submission of a Plan of Compliance to NYSE American (PR Newswire)
Jun-22-22 05:00PM	China Pharma Announces Receipt of Noncompliance Notice from NYSE American (PR Newswire)
08:00AM	Loading…
Mar-31-22 08:00AM	China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results (PR Newswire)
Nov-12-21 04:30PM	China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results (PR Newswire)
Aug-13-21 04:30PM	China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results (PR Newswire) -15.90%
Aug-05-21 09:00AM	China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval (PR Newswire)
Jun-09-21 08:00AM	China Pharma to Launch Highly Purified NMN+PQQ Product (PR Newswire)
May-14-21 04:30PM	China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue (PR Newswire)
Apr-19-21 08:30AM	China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port (PR Newswire) +5.76%
Mar-26-21 05:00PM	China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results (PR Newswire) +37.04%
Nov-13-20 04:10PM	China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results (PR Newswire)
Oct-11-20 09:23AM	A Quick Analysis On China Pharma Holdings' (NYSEMKT:CPHI) CEO Salary (Simply Wall St.)
Sep-21-20 08:30AM	China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks (PR Newswire)
Aug-14-20 06:30AM	China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results (PR Newswire)
Aug-11-20 10:10AM	CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET (PR Newswire) +7.13%
Jun-04-20 07:59PM	Edited Transcript of CPHI earnings conference call or presentation 15-May-20 12:30pm GMT (Thomson Reuters StreetEvents)
May-15-20 06:30AM	China Pharma Holdings, Inc. Reports First Quarter 2020 Financial Results (PR Newswire) -7.02%
08:00AM	Loading…
Apr-15-20 08:00AM	China Pharmaceutical Holdings Co., Ltd. Added Mask Production Lines (PR Newswire) +25.56%
Apr-14-20 04:30PM	Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results (PR Newswire) +10.67%
07:10AM	How Much is China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Getting Paid? (Simply Wall St.)
Apr-05-20 01:17AM	Edited Transcript of CPHI earnings conference call or presentation 31-Mar-20 12:30pm GMT (Thomson Reuters StreetEvents)
Mar-31-20 06:30AM	China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results (PR Newswire) -24.91%
Mar-13-20 08:30AM	CPHI to Hold Fiscal Year 2019 Earnings Conference Call On Tuesday March 31, 2020 at 8:30 a.m. ET (PR Newswire) -9.76%
Mar-02-20 07:00AM	China Pharmaceutical Holdings Co., Ltd. Launched A New Product (PR Newswire) +100.00%
Dec-31-19 08:01AM	China Pharma Holdings, Inc. (NYSEMKT:CPHI): What Does Its Beta Value Mean For Your Portfolio? (Simply Wall St.)
Nov-15-19 08:00AM	China Pharma Holdings, Inc. Reports Third Quarter 2019 Financial Results (PR Newswire)
Oct-28-19 07:39AM	Introducing China Pharma Holdings (NYSEMKT:CPHI), A Stock That Climbed 37% In The Last Three Years (Simply Wall St.)
Sep-13-19 07:17AM	Our Take On China Pharma Holdings, Inc.'s (NYSEMKT:CPHI) CEO Salary (Simply Wall St.)
Sep-11-19 08:00AM	China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd. (PR Newswire)
Sep-06-19 08:31AM	Edited Transcript of CPHI earnings conference call or presentation 15-Aug-19 12:30pm GMT (Thomson Reuters StreetEvents)
Aug-15-19 06:30AM	China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results (PR Newswire)
May-21-19 07:56PM	Edited Transcript of CPHI earnings conference call or presentation 15-May-19 12:30pm GMT (Thomson Reuters StreetEvents)
May-15-19 06:00AM	China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results (PR Newswire)
May-07-19 08:00AM	CPHI to Hold First Quarter 2019 Earnings Conference Call On Wednesday, May 15, 2019 at 8:30 a.m. ET (PR Newswire) -5.32%
Mar-29-19 06:00AM	China Pharma Holdings, Inc. Reports Fiscal Year 2018 Financial Results (PR Newswire)
Jan-08-19 12:58PM	Top 3 Healthcare Penny Stocks for 2018 (Investopedia)
Nov-23-18 08:55AM	Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group Discovering Underlying Factors of Influence (GlobeNewswire)
Nov-15-18 06:00AM	China Pharma Holdings, Inc. Reports Third Quarter 2018 Financial Results (PR Newswire) -9.27%
Nov-13-18 08:00AM	China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO® (PR Newswire) +20.00%
Nov-12-18 08:00AM	CPHI to Hold Third Quarter 2018 Earnings Conference Call On Thursday, November 15, 2018 at 8:30 a.m. ET (PR Newswire) -9.06%
Oct-10-18 06:44PM	Top 3 Healthcare Penny Stocks for 2018 (Investopedia) -8.30% -8.07%
Aug-15-18 06:00AM	China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results (PR Newswire) -6.33%
Aug-06-18 08:45AM	CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET (PR Newswire) -7.13%
May-15-18 08:00AM	Free Stock Performance Review on Pfizer and Three More Drug Makers Stocks (ACCESSWIRE)
06:00AM	China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results (PR Newswire)
May-08-18 08:00AM	CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET (PR Newswire)
Apr-06-18 07:40AM	Wired News Eli Lilly's Phase-3 REACH-2 Study of CYRAMZA(R) Met its Primary Endpoint of Overall Survival (ACCESSWIRE)
Apr-05-18 07:10AM	Blog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSD (ACCESSWIRE)
Apr-03-18 06:00AM	China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results (PR Newswire) -12.64%
Mar-22-18 08:00AM	CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET (PR Newswire)
Dec-01-17 07:58AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017 (Capital Cube)
Nov-15-17 06:00AM	China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results (PR Newswire)
Nov-08-17 12:20PM	Top 3 Healthcare Penny Stocks for 2017 (Investopedia) +13.24%
Nov-07-17 08:00AM	CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET (PR Newswire)
Oct-24-17 03:48PM	Does China Pharma Holdings Incs (CPHI) Debt Level Pose A Serious Problem? (Simply Wall St.)
Sep-26-17 12:03PM	China Pharma Holdings Inc (CPHI): What Does It Mean For Your Portfolio? (Simply Wall St.) -15.00%
Sep-14-17 07:40AM	Corporate News Blog - GlaxoSmithKline Declares Publication of Phase-III Results Of Mepolizumab in Patients with Eosinophilic COPD at Risk of Exacerbations (ACCESSWIRE)
Sep-12-17 04:05PM	China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency (PR Newswire) +7.68%
Aug-16-17 10:08AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 (Capital Cube)
Aug-15-17 06:00AM	China Pharma Holdings, Inc. Reports Second Quarter 2017 Financial Results (PR Newswire)
Aug-08-17 06:00AM	CPHI to Hold Second Quarter 2017 Earnings Conference Call On Tuesday August 15, 2017 at 8:30 a.m. ET (PR Newswire)
May-24-17 09:18AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 (Capital Cube) +6.95%
May-17-17 08:30AM	China Pharma Holdings, Inc.'s Wholly-owned Subsidiary Participated in PharmChina/API China Conferences (PR Newswire) +13.33%
May-12-17 06:00AM	China Pharma Holdings, Inc. Reports First Quarter 2017 Financial Results (PR Newswire)
May-08-17 06:00AM	CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET (PR Newswire)
Apr-04-17 08:41AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017 (Capital Cube)
Mar-31-17 06:11AM	CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
06:00AM	China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results (PR Newswire)
Mar-27-17 06:00AM	CPHI to Hold Fiscal Year 2016 Earnings Conference Call On Friday March 31, 2017 at 8:30 a.m. ET (PR Newswire)
Dec-28-16 04:06PM	CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Other Events
Dec-13-16 04:08PM	CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -11.15%
Dec-02-16 04:11PM	CHINA PHARMA HOLDINGS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements a
Nov-22-16 01:04PM	CHINA PHARMA HOLDINGS, INC. Financials
Nov-18-16 11:50AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (Capital Cube)
Nov-15-16 06:00AM	China Pharma Holdings, Inc. Reports Third Quarter Financial Results (PR Newswire)
Nov-14-16 04:12PM	CHINA PHARMA HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report -8.33%
Nov-07-16 08:00AM	CPHI to Hold Third Quarter 2016 Earnings Conference Call On Tuesday November 15, 2016 at 8:30 a.m. ET (PR Newswire)
Aug-12-16 06:00AM	China Pharma Holdings, Inc. Reports Second Quarter Financial Results (PR Newswire) -5.81%
Aug-11-16 04:27PM	CHINA PHARMA HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
Aug-01-16 06:00AM	CPHI to Hold Second Quarter 2016 Earnings Conference Call on Friday August 12, 2016 at 8:30 a.m. ET (PR Newswire)
Jun-06-16 12:12PM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
May-17-16 06:00AM	China Pharma Holdings, Inc. Reports First Quarter Financial Results (PR Newswire) -5.44%
May-16-16 05:17PM	CHINA PHARMA HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
May-05-16 06:00AM	CPHI to Hold First Quarter 2016 Earnings Conference Call on Tuesday May 17, 2016 at 8:30 a.m. ET (PR Newswire)
Apr-05-16 11:33AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q4, 2015 By the Numbers
10:27AM	China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: 2015 By the Numbers
Mar-31-16 06:00AM	China Pharma Holdings, Inc. Reports Full Year 2015 Financial Results (PR Newswire) -14.79%

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

China Pharma Holdings Inc

Upgrade your FINVIZ experience